| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Galera Therapeutics, Inc.
13D
GRTX · 36338D108
|
6.7% |
6/11/2026
Event 5/15/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.